# Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii

> **NCT03997279** · PHASE4 · UNKNOWN · sponsor: **Clinical Centre of Serbia** · enrollment: 200 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Saccharomyces boulardii
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03997279
- **Lead sponsor:** Clinical Centre of Serbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03997279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03997279, "Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03997279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*